Media Summary: In this episode of the Oncology Brothers podcast, we dived deep into the recent FDA approvals for Dr Punie discusses the patient-reported outcomes (PROs) from the Phase Sacituzumab govitecan improves PFS in first-line metastatic TNBC patients unable to receive PD-(L)1 inhibitors Dr Javier ...
Ascent 03 Sacituzumab Govitecan Improves - Detailed Analysis & Overview
In this episode of the Oncology Brothers podcast, we dived deep into the recent FDA approvals for Dr Punie discusses the patient-reported outcomes (PROs) from the Phase Sacituzumab govitecan improves PFS in first-line metastatic TNBC patients unable to receive PD-(L)1 inhibitors Dr Javier ... Dr Aditya Bardia spoke to ecancer online about the the randomised phase Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, provides an overview of the Phase III ... Breast Cancer Research at ESMO25: Dr. Sara Tolaney details research in The New England Journal of Medicine showing the ...
Kevin Kalinsky, MD, MS, Emory University Hospital, Atlanta, GA, discusses the results of a study looking at real-world Dr Sara Tolaney highlights exploratory biomarker analyses from the phase Sara M. Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, outlines the updated biomarker analysis results of the ... Aditya Bardia, MD, MPH, Massachusetts General Hospital, Boston, MA, discusses the results from the Sara Tolaney, MD, MPH, Dana Farber Cancer Institute, Boston, MA, describes the trial design and rationale of the Phase III ... Dr Tolaney talks to ecancer about results she presented at ASCO 2025 from an international phase
Sara Hurvitz, MD, Ronald Reagan UCLA Medical Center, Los Angeles, CA, discusses the results of the
